To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
16 Current news about the topic oligonucleotidesrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Palo Alto -September 4- Varian, Inc. (Nasdaq:VARI) announced today the Fluorescence BioMelt™ system, a turnkey, application-specific package for studying the thermal characteristics of DNA and proteins. Several unprecedented innovations in the system's sample handling and software significantly ...
Pan® Oligo Sets is the brand name for MWG-Biotech’s new oligonucleotide sets that enable customers to produce their own oligonucleotide microarrays (DNA chips). The sets are based on the competence and the success of MWG-Biotech’s Pan® Array series of catalogue DNA chips and on the high ...
Aventis Pharma and Coley Pharmaceutical Group, Inc. have entered into a product development and licensing agreement for first-in-class asthma and allergic rhinitis products based on Coley’s novel CpG immune modulators. The agreement provides Aventis with an exclusive, worldwide, royalty-bearing ...
Introducing co-branded genome-wide oligonucleotide collections for high-throughput analysis of gene function SAN DIEGO, Jun 25, 2001 (BW HealthWire) -- Sigma-Genosys, a member of the Sigma-Aldrich family (NASDAQ:SIAL), and Compugen (NASDAQ:CGEN) announced today at the Bio 2001 meeting in ...
Accelrys Inc., a subsidiary of Pharmacopeia, Inc. (NASDAQ: PCOP), has released Version 10.2 of the GCG Wisconsin Package™, the well respected sequence analysis package used at over 650 institutions worldwide. Version 10.2 extends the Package's profile analysis tools by supplying Dr. Sean ...
Affymetrix holds over 140 important patents for expression profiling, mutation analysis, genotyping and SNP analysis. Any company who wants to enter this market, be it for basic research, for the development of new medications, or for disease diagnostics, needs to acquire a licence from ...